Inside Drug Pricing

Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

The White House wants the drug industry to know it is playing hardball on drug pricing. Just two months after unveiling a drug pricing plan, which some said raised more questions than answers, the Trump administration is mounting a pressure campaign meant to stem the tide of rising drug prices, as the administration hashes out what policy changes it will pursue. 

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.